life and annuity market update...v:\_towers watson internal\rcs\people\sands,...
TRANSCRIPT
Life and Annuity Market Update
John Fenton, FSA, MAAA
November 2014
Southeastern Actuaries Club
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Overview of presentation
U.S. Annuity Market
Sales trends
Key issues
Products
U.S. Life Market
Sales trends
Key issues
Products
Regulatory Outlook
Longevity Trends
towerswatson.com
OVERVIEW
1
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
U.S. Annuity Market
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Total annuity sales levels have been fairly stable over
recent years
*Excludes structured settlements
Sources: Towers Watson VALUE Survey, LIMRA
5.0 5.5 6.8 11.8 14.4 23.1 27.2 25.3 25.2 26.7 30.1 32.3 32.2 33.9 39.3 45.2 37.1 47.3 64.7
86.8 67.2 61.3 45.8 44.7 41.4
76.2 75.1 44.0 43.2 33.4
39.7 44.4
122.0
137.7 114.0
116.0 128.5 134.0
137.5 160.0
186.0
157.5 127.1
140.0 159.0
146.9 146.5
141.0
0
50
100
150
200
250
300
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014A
$ B
illi
on
s
Indexed annuity sales Fixed annuity sales* Variable annuity sales
ANNUITY MARKET
towerswatson.com
3
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Interest rates have risen since early in 2013, although rates
remain low; 10 year Treasury yield now approximately 2.x%
© 2014 Towers Watson. All rights reserved.
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx towerswatson.com
4
4.63
3.66 3.26 3.21
2.78
2.04 1.82
1.64 1.71 1.95 1.99
2.71 2.75 2.76 2.62 2.50
5.89
7.28 6.31
4.52 4.22
3.74 3.52
2.95 2.72
2.94 3.20
3.74 3.68 3.54 3.36 3.36
6.24
7.84 7.48
5.12 4.80
4.37 4.25
3.80 3.58 3.72
4.01
4.63 4.50 4.29
3.96 3.96
8.52 8.19
7.72
7.11 7.23
6.72 6.46
6.19 6.17
6.61 6.28
5.99 5.62
5.79
0
1
2
3
4
5
6
7
8
9
20
07
20
08
20
09
20
10
20
11
1Q
2012
2Q
2012
3Q
2012
4Q
2012
1Q
2013
2Q
2013
3Q
2013
4Q
2013
1Q
2014
2Q
2014
3Q
2014
Yie
ld (
%)
Period
Average Yield Rates from January 2007 to June 2014
10 Year CMT A Yield BBB Yield High Yield
Double digit high
Source: Bloomberg (BofA Merrill Lynch US Corporate 7-10y Yields and CMT data)
ANNUITY MARKET
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
VA product/market trends
Prior market leaders — Prudential and Met — continue their pullback
Others try to manage sales (expect year-end restrictions)
Continued implementation of volatility controlled funds
Now accounts for approximately $200B of total funds
Initially on new products but several insurers have now implemented on inforce
Products with living benefits remain main sellers but investment only products have gained traction
Jackson National (Elite Access) has quarterly run rate of $1B
Prudential reports 10% of sales, Ameriprise 25%
Jefferson National’s Monumental was sector leader ($200M quarterly run rate)
Others have introduced product fairly recently (Met, Lincoln)
Living benefit products
Some limited enhancements (before interest rates dropped again)
Becoming more common now to vary “rates” (monthly rate sheet)
Buyback programs continue — AXA and Hartford supplemented existing programs, Voya added
Some ongoing changes to inforce
towerswatson.com
5
ANNUITY MARKET
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Fixed annuity sales have been increasing since 2012
Annualized sales up 18% so far in 2014, strong gains in most product
types
6
towerswatson.com
YTD Q2 2014 2013 2012 % Change
(YTD Q2 2014 vs. 2013)
Book Value 11.2 22.4 20.2 +0%
Indexed 24.3 39.3 33.9 +24
MVA 4.6 6.9 4.5 +33
Immediate* 6.4 10.5 8.7 +22
Total Fixed ̂ 46.5 79.1 67.3 +18
* Includes deferred income
^ Excludes structured settlements
Source: LIMRA, sales in billions
ANNUITY MARKET
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Key issues in fixed annuity market
Indexed annuity sales continue to grow
Many products use GWLBs to drive sales — focus on income story
Sales expanding to lower commission distribution channels
Major players have added managed volatility funds — and removed cap on
index return (caps have otherwise been in 3-4% range)
More traditional fixed annuities (MVA and BV) have been helped by
rise in rates since 2013
Sales are still relatively low
Companies with alternative asset strategies have helped boost market
Growth in SPIA and particularly DIAs
7
towerswatson.com
ANNUITY MARKET
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
SPIA trends
Several companies refreshing their product pricing
Mortality and investment focus
Refresh pricing models, but few have expanded to full ALM models
Profit margins can be very thin from low statutory reserves
Mortality viewpoints can differ substantially by company
Base mortality
Mortality selection
Mortality improvement
Investment yield assumptions
Quality level, private securities, mortgages and alternative assets usually
driving differences by company
New reserve table in 2015? - 2012 IAR vs. Annuity 2000
8
towerswatson.com
ANNUITY MARKET
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Common DIA product features
Single or flexible premium
Single or joint life; continuation %
Guaranteed payments
Return of Premium (ROP) or period certain
Wide range of ages/deferrals
Purchase from Age 18 to 70+
Deferral from 1+ to 30 years+/Age 70½ qualified
Change of deferral period
Based on commutation rate and mortality table
Some with limited liquidity
Acceleration of payments (some or all)
Increasing income options
Fixed percentage per year (1%, 2%, 3% or 4%)
Dividend based (Northwestern Mutual)
9
towerswatson.com
ANNUITY MARKET
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
“Hybrid” annuities are gaining interest
More downside risk than IA (can invade principal) but offers some
protection (more than VA)
Greater upside than IA via higher cap rates
Two main design types
Buffer design: first x% of losses is absorbed by company (buffer to
policyholder), but PH pays losses beyond that
Floor design: first y% of losses is paid for by PH, then a floor
AXA had original product, more recent entries by MetLife, Allianz,
CUNA Mutual, and VOYA
Invades principal so must be a registered product
The cost of hedging is generally less due to less volatility in claims
levels, given that the vast majority of investments are in fixed income
securities and index exposure is limited to index based call spreads
10
towerswatson.com
ANNUITY MARKET
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
U.S. Life Market
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
towerswatson.com
12
LIFE MARKET
12
Source: LIMRA International Market Trends, TW analysis. Based on first-year (weighted) premium; 100% of planned ongoing premium plus 10% of
single premium
Industry Average Annual Growth Rate (Based on Premiums)
Increases generally 4% a year since 2009, jumping up to 6% in 2012
Sales growth by premium have consistently outpaced sales growth by face amount/number of
policies (not shown), indicating that sales growth is coming from premium oriented policies
YTD sales are down in 2014
Ind
ustr
y S
ale
s
($ M
illio
ns)
After a significant decline in 2007-2009, life insurance sales have
increased steadily (but not spectacularly); however, 2013 was flat
1995 – 2005 2007 – 2009
$9,000
$10,000
$11,000
$12,000
$13,000
$14,000
$15,000
1995 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
2009 – 2011 CAGR:
0.0%
2012 2013
6.0% 4.0% -9.9% 6.9% 2.7%
2005 – 2007
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
towerswatson.com
13
Universal life (including IUL) remains the leading product
type
4 7
36
14 5
82
47
54
23
24 35
38 26
18
39 38
18 11 13
23 23 22
1980 1985 1990 2000 2005 2013
Variable Universal Life Whole Life Universal Life Term
Market Share of Individual Life Insurance by Product Type
(Percent of Total FY Premium)
^ IUL included here and represents 13% of total
Source: LIMRA International. Based on first-year premium. Results based on policies issued would be significantly different.
Sales Growth 2Q YTD
2014 vs. 2013
UL -12%*
WL +1%
Term -3%
VUL +29%
Total -4%
* Includes IUL
LIFE MARKET
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
^
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
towerswatson.com V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
14
Life insurance sales remain low
Life insurance sales have rebounded somewhat since GFC (2008)
levels, but still not attracting as much premiums
STOLI has not recovered
Savings dollars going elsewhere
Life insurance agents, in general, are getting older
Life ownership levels lowest in years
We need a new approach
Some believe streamlined underwriting is the answer
LIFE MARKET
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
towerswatson.com V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
15
Elements of a streamlined underwriting approach
Principal’s accelerated underwriting approach is an example of this
Individuals up to age 60 can qualify for face amounts up to $1 million
without paramedical exam or bodily fluids
Combines short-app questionnaire from agent with tele-app, MVR, MIB,
prescription check
Preferred Plus and Preferred risk classes
Underwriting completion within 48 hours from tele-app
Full agent compensation
Issue/UW expense savings help pay for (any) extra mortality
May be possible to take elements of this approach to appeal to young
demographics
Social media based solicitation
Target life style changes
Tie in with affinity groups
LIFE MARKET
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
towerswatson.com
LIFE MARKET
16
Life insurance combo products
Often a rider that can be attached to any type of permanent life
product
Insured can accelerate all or a portion of face amount for LTC benefits
Must meet eligibility requirements
A small percentage (2%-4%) of face available per month until face
exhausted
Extension of benefits option: more than face is available for LTC
Feature is financed via an additional premium or account charge
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
towerswatson.com
LIFE MARKET
17
Growth of combo products
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Life combo product premium grew 12% in 2013 5th consecutive
year of double-digit growth
0.8
1.3
2.2 2.4
2.6
-
0.5
1.0
1.5
2.0
2.5
3.0
2009 2010 2011 2012 2013
Combo Product Premium (billions)
WL 14%
UL 83%
VUL 3%
2013 Product Distribution
Source: LIMRA 2014 Individual Life Combination Products Annual Review
Regulatory Outlook
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
PBR now appears likely to actually happen
The NAIC (narrowly) approved the Valuation Manual in early December 2012
The Valuation Manual must go through the state legislative approval process
before becoming operative
The Valuation Manual will become operative on January 1st following the first
July 1 in which both of the following occur:
Adoption by 42 states (out of 56 jurisdictions, or 75%); known as the supermajority
Adoption by enough states that represent at least 75% of industry direct premiums in
2008
18 states have already enacted (representing 28.0% of premium)
19 states have indicated they are committed to adopting in 2014/2015
(representing 45.1% of premium)
This leaves 5 states and 1.9% of premium to go
Even without California and New York, there are enough states to push it
across the finish line
towerswatson.com
19
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
So, we suggest it is time to start planning more earnestly
for this — January 1, 2017 operative date is likely
REGULATORY OUTLOOK
Longevity Trends
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
U.S. population mortality improvement has seen some
shifts over the past 30 years
21
Annual Average Improvement in Mortality 1979-2010
Period Gender 25-34 35-44 45-54 55-64 65-74 75-84 85+
1979-2000 Male 1.5% 0.8% 1.7% 1.8% 1.4% 1.0% 0.0%
Female 0.8 0.6 1.3 0.8 0.4 0.4 -0.3
Combined 1.3 0.7 1.5 1.4 0.9 0.6 -0.2
2000-2010 Male -0.2 1.8 0.7 1.3 2.7 2.0 1.3
Female -0.1 1.0 0.0 1.8 2.3 1.5 1.1
Combined -0.1 1.5 0.4 1.5 2.4 1.7 1.1
1979-2010 Male 1.0 1.1 1.4 1.7 1.8 1.3 0.4
Female 0.5 0.7 0.9 1.1 1.0 0.8 0.1
Combined 0.8 1.0 1.2 1.4 1.4 1.0 0.2
Combined rates reflect a 50%-50% blend (a simplifying assumption)
Source: Derived from CDC mortality database
LONGEVITY TRENDS
towerswatson.com V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Cause of death trends can be examined to better
understand mortality improvement drivers
22
Historical Annual Mortality Improvement for Selected Causes of Death 2000-2010
Ages: 45-54 55-64 65-74 75-84 85+
Males
Heart Disease 1.7% 3.2% 4.7% 4.1% 2.8%
Malignant Neoplasms (e.g., Cancer) 1.4 1.9 2.4 1.5 1.0
Cerebrovascular Disease 1.6 3.0 4.5 5.0 5.0
Nephritis, Nephrotic Syndrome, and Nephrosis -0.6 -1.5 -0.6 -1.1 -1.3
Alzheimer's -0.8 -0.1 0.0 -2.6 -4.2
Accidents -2.1 -2.3 -0.6 -0.9 -1.2
Females
Heart Disease 0.7% 3.7% 5.0% 4.3% 3.5%
Malignant Neoplasms (e.g., Cancer) 1.3 2.2 1.7 0.8 0.5
Cerebrovascular Disease 2.3 3.7 4.5 4.3 4.4
Nephritis, Nephrotic Syndrome, and Nephrosis -2.0 -0.1 0.0 -1.5 -1.9
Alzheimer's -8.0 -0.2 -1.1 -3.0 -4.1
Accidents -5.6 -2.3 0.0 -1.3 -2.2
Source: Derived from CDC mortality database
LONGEVITY TRENDS
towerswatson.com V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
In order to help predict future trends, we have developed
a cause of death projection model
This develops results by major cause of death, varying by period, age,
and gender
In general, shows lower rates of improvement in later years
Roughly 50% of initial rates after 30 years
Our model can also be used to examine the impact of significant
events, e.g., a cure for cancer
We suggest using prudence for longer projection periods
Higher rates for longevity risk
Lower rates for mortality risk
Could also consider netting risks
Expect corporate to provide guidance on this
23
LONGEVITY TRENDS
towerswatson.com V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
We have also studied other factors
Socioeconomic
Our analysis suggests up to a 1.5% difference (i.e., 1.0% vs. 2.5%) for low
vs. high earners
Cohort effect (i.e., vary by birth years)
Data show some limited evidence of cohort effect in U.S. (males born in
1930-40, males born in 1920-30, females born in 1930-40)
Smoking prevalence
The reduction in smoking prevalence may have contributed .2-.3% annual
mortality improvement over the past decade (i.e., 1.0% goes to 1.2-1.3%),
but given recent stabilization in smoking prevalence this is unlikely to lead to
future contributions
Obesity
Rising levels of obesity could lead to a .25% per annum reduction in
mortality improvement in the future
24
LONGEVITY TRENDS
towerswatson.com V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx
All of these are studied in the recent Towers Watson
White Paper “Longevity Trends in the United States”
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
25
Contact information
CONTACT
towerswatson.com
John Fenton, FSA, MAAA
Director
3500 Lenox Road, Suite 900 T +1 404 365 1619
Atlanta, GA 30326-4238
V:\_Towers Watson Internal\RCS\People\Sands, Ann-Marie\POWER\SEAC-Life and Annuity Market Update-Nov 14.pptx